Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-04-020610
Filing Date
2004-04-14
Accepted
2004-04-14 15:52:57
Documents
2
Period of Report
2004-04-14

Document Format Files

Seq Description Document Type Size
1 rrd38676.html 3  
1 rrd38676.xml 3 17886
3 POWER OF ATTORNEY rrd30239_35043.htm EX-24. 1315
  Complete submission text file 0001181431-04-020610.txt   21020
Mailing Address
Business Address 275 MIDDLEFIELD ROAD SUITE A MENLO PARK CA 94025
CORCEPT THERAPEUTICS INC (Issuer) CIK: 0001088856 (see all company filings)

EIN.: 770487658
SIC: 2834 Pharmaceutical Preparations

Mailing Address AMYLIN PHARMACEUTICALS INC 9360 TOWNE CENTRE DR SAN DIEGO CA 92121
Business Address AMYLIN PHARMACEUTICALS INC 9360 TOWNE CENTRE DR SAN DIEGO CA 92121 8585522200
WILSON JAMES N (Reporting) CIK: 0001236387 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50679 | Film No.: 04733113